Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 193Lung Neoplasms 80Pancreatic Neoplasms 47Neoplasms 31Non-Squamous Non-Small Cell Lung Cancer 19Head and Neck Neoplasms 19Glioblastoma 19Adenocarcinoma of Lung 19Squamous Cell Carcinoma of Head and Neck 18Neoplasm Metastasis 17Gliosarcoma 17Brain Neoplasms 17Breast Neoplasms 16Rectal Neoplasms 13Colorectal Neoplasms 13Colonic Neoplasms 13Adenocarcinoma, Bronchiolo-Alveolar 13Carcinoma, Hepatocellular 11Carcinoma, Renal Cell 10Glioma 8Astrocytoma 8Salivary Gland Neoplasms 7Gallbladder Neoplasms 7Esophageal Neoplasms 7Carcinoma, Ovarian Epithelial 7Prostatic Neoplasms 6Ovarian Neoplasms 6Oligodendroglioma 6Fallopian Tube Neoplasms 6Carcinoma, Squamous Cell 6

Interventions

Filgrastim 11Temozolomide 9Peripheral Blood Stem Cell Transplantation 6Carboplatin 5Irinotecan 4sargramostim 3Oxaliplatin 3O(6)-benzylguanine 3Cyclophosphamide 3Vorinostat 2Vincristine 2Thiotepa 2Psychiatric Rehabilitation 2Granulocyte Colony-Stimulating Factor 2Everolimus 2Etoposide 2Cisplatin 2Carmustine 2Busulfan 2veliparib 1trioctyl phosphine oxide 1romidepsin 1ribociclib 1phenylacetic acid 1palbociclib 1olaparib 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Familial ependymoma × Erlotinib Hydrochloride × Clear all
NCT00077454 2013-06-05

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
95 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Medulloblastoma, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡